Lingotto Investment Management LLP Acquires Shares of 7,110 UnitedHealth Group Incorporated (NYSE:UNH)

Lingotto Investment Management LLP purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 7,110 shares of the healthcare conglomerate’s stock, valued at approximately $3,597,000.

Other large investors have also added to or reduced their stakes in the company. AMF Tjanstepension AB increased its stake in shares of UnitedHealth Group by 88.0% during the third quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock valued at $151,374,000 after buying an additional 121,180 shares during the period. Hudson Value Partners LLC increased its position in UnitedHealth Group by 8.3% during the 3rd quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock valued at $625,000 after purchasing an additional 82 shares during the period. Wealth Group Ltd. lifted its position in shares of UnitedHealth Group by 4.0% in the 3rd quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock worth $1,039,000 after purchasing an additional 68 shares during the period. Howard Capital Management Group LLC purchased a new position in shares of UnitedHealth Group during the third quarter valued at about $341,000. Finally, GSG Advisors LLC lifted its holdings in UnitedHealth Group by 14.4% in the third quarter. GSG Advisors LLC now owns 746 shares of the healthcare conglomerate’s stock worth $435,000 after buying an additional 94 shares during the period. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently commented on UNH. Piper Sandler lowered their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Barclays dropped their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Wells Fargo & Company lowered their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Stephens raised their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Finally, Oppenheimer upped their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and an average target price of $629.32.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.33% of the stock is owned by insiders.

UnitedHealth Group Trading Up 1.9 %

NYSE:UNH opened at $470.49 on Wednesday. The company has a 50 day simple moving average of $518.22 and a two-hundred day simple moving average of $559.08. The company has a market cap of $432.99 billion, a PE ratio of 30.35, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the prior year, the company earned $5.83 earnings per share. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.79%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.